Sr. Finance Manager

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve – we care.

What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow’s health today, we want to hear from you.

Position Summary

The Sr. Manager, Cell & Gene Therapy Financial Performance plays a critical role within US Oncology Network (USON) Finance by serving as the subject matter expert for the financial performance of Cell & Gene therapies across the network. This position is accountable for developing the financial performance framework for Cell & Gene—including definitions, measurement methodology, and executive-ready reporting—while partnering closely with practices and cross-functional stakeholders to ensure performance is understood, accurate, and actionable.

This role translates complex, evolving therapy economics into clear financial insights for executive leadership. It leads modeling and scenario analysis across key drivers (utilization, site-of-care dynamics, acquisition and reimbursement, program costs, and timing impacts), and it establishes repeatable reporting that supports decision-making, performance improvement, and strategic planning.

Operating at the intersection of finance, operations, and strategy, the Sr. Manager drives continuous improvement in data quality, analytical tools, and governance for Cell & Gene financial performance. By maintaining disciplined, transparent analytics and communicating results with executive presence, this role supports USON’s mission and enables sound financial stewardship as these therapies scale.

Key Responsibilities

• Serve as the finance subject matter expert for Cell & Gene Therapy performance across USON, owning the end-to-end performance measurement approach (definitions, key metrics, methodology, and controls).

• Establish standardized performance views and interpretation guidelines to ensure consistent understanding across practices and stakeholders.

• Lead development and refinement of financial models that explain and forecast Cell & Gene performance, focusing on transparency, accuracy, and decision usefulness.

Practice & Stakeholder Partnership / Performance Determination

• Partner directly with practices and key stakeholders (FP&A, Finance Ops, Revenue Cycle, Managed Care, operations/clinical partners as applicable) to determine and validate Cell & Gene financial performance.

• Investigate performance drivers and variances, ensuring results are well-supported, reconciled, and communicated in business terms.

• Translate practice-specific realities into consistent network-level reporting and comparable performance narratives.

Executive Reporting & Decision Support

• Deliver concise, executive-ready reporting packages, including performance commentary, variance explanations, and forward-looking outlooks.

• Present findings and recommendations with strong executive presence, tailoring content for senior leadership decision-making.

• Build “so what” insight: clarify risks, opportunities, and key actions based on the financial performance signals.

Modeling, Scenario Planning & Forecasting

• Develop scenario models (volume, timing, reimbursement sensitivity, program cost structures) to support budgeting/forecasting and strategic planning for Cell & Gene growth.

• Create driver-based views that allow leadership to understand what is changing, why, and what levers exist.

• Support annual planning cycles and in-year updates with disciplined assumptions and documented logic.

Data, Reporting Automation & Visualization

• Build and enhance repeatable reporting and dashboards (Excel and/or Power BI) that provide timely, accurate Cell & Gene financial performance visibility.

• Improve efficiency through automation and standardized data pipelines, while maintaining strong data governance and controls.

• Ensure reporting is consistent, auditable, and easy for business partners to consume.

Strategic Initiatives, Governance & Continuous Improvement

• Lead or contribute to strategic initiatives related to Cell & Gene financial performance measurement, pr